AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 98 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,452,000 | -62.2% | 24,000 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $3,840,000 | -66.0% | 24,000 | 0.0% | 0.00% | -66.7% |
Q1 2022 | $11,280,000 | -17.5% | 24,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $13,680,000 | -65.7% | 24,000 | 0.0% | 0.00% | -70.0% |
Q3 2021 | $39,840,000 | -1.8% | 24,000 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $40,560,000 | -8.6% | 24,000 | 0.0% | 0.01% | -9.1% |
Q1 2021 | $44,400,000 | +16.4% | 24,000 | 0.0% | 0.01% | +10.0% |
Q4 2020 | $38,160,000 | +66.1% | 24,000 | 0.0% | 0.01% | +42.9% |
Q3 2020 | $22,968,000 | +50.3% | 24,000 | 0.0% | 0.01% | +40.0% |
Q2 2020 | $15,286,000 | +20.2% | 24,000 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $12,720,000 | -24.4% | 24,000 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $16,824,000 | – | 24,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |